Dikoglu E, Pareja F
Adv Exp Med Biol. 2025; 1464():237-257.
PMID: 39821029
DOI: 10.1007/978-3-031-70875-6_13.
Walker J, Patel S, Cobain E, Kleer C, Neal C, Migyanka F
Curr Psychiatry Rep. 2024; 27(2):98-104.
PMID: 39688786
DOI: 10.1007/s11920-024-01578-1.
Zarei T, Hosseini-Bensenjan M, Haghpanah S, Abedi E, Parand S, Ramzi M
Int Cancer Conf J. 2024; 13(4):326-335.
PMID: 39398916
PMC: 11465019.
DOI: 10.1007/s13691-024-00697-z.
Kioleoglou Z, Georgaki E, Koufopoulos N, Kostek O, Volakakis N, Dimitriadou A
Cureus. 2024; 16(7):e65852.
PMID: 39219935
PMC: 11364151.
DOI: 10.7759/cureus.65852.
Mushtaq A, Lawal I, Muzahir S, Friend S, Bhave M, Meisel J
Eur J Nucl Med Mol Imaging. 2024; 51(13):4073-4082.
PMID: 38976035
PMC: 11824347.
DOI: 10.1007/s00259-024-06830-7.
Small bowel obstruction as first presentation of metastatic lobular breast cancer for pilgrim patient.
Alsobahi N, Mohammed T
Int J Surg Case Rep. 2024; 120:109855.
PMID: 38865947
PMC: 11258619.
DOI: 10.1016/j.ijscr.2024.109855.
Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights.
Batra H, Mouabbi J, Ding Q, Sahin A, Raso M
Cancers (Basel). 2023; 15(22).
PMID: 38001750
PMC: 10670219.
DOI: 10.3390/cancers15225491.
Traumatic sigmoid colon rupture due to breast cancer metastasis: a case report.
Yoshida T, Ide M, Katayama K, Yanai M, Kurosaki R, Shimizu H
Clin J Gastroenterol. 2023; 16(6):854-858.
PMID: 37733231
DOI: 10.1007/s12328-023-01859-x.
Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma.
Bonnin D, Ladoire S, Briot N, Bertaut A, Drouet C, Cochet A
J Clin Med. 2023; 12(8).
PMID: 37109252
PMC: 10144846.
DOI: 10.3390/jcm12082916.
The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer.
Nagtegaal I, Snoek J, Bult P, Tol J, Siesling S, Voorham Q
Clin Exp Metastasis. 2023; 40(3):205-216.
PMID: 37106226
PMC: 10232590.
DOI: 10.1007/s10585-023-10207-9.
Combination of Conventional Drugs with Biocompounds Derived from Cinnamic Acid: A Promising Option for Breast Cancer Therapy.
de Freitas Meirelles L, Souza M, Carobeli L, Morelli F, Mari N, Damke E
Biomedicines. 2023; 11(2).
PMID: 36830811
PMC: 9952910.
DOI: 10.3390/biomedicines11020275.
Bilateral Pleural Effusion Revealing a Rare Breast Tumor: A Case Report.
Nabou O, Baddi F, Haloui O, Musallam M, Thouil A, Kouismi H
Cureus. 2023; 14(12):e32312.
PMID: 36628009
PMC: 9824749.
DOI: 10.7759/cureus.32312.
Gastrointestinal Tract Metastases of Invasive Lobular Carcinoma of the Breast: An Immunohistochemical Survey Algorithm.
Zengel B, Cavdar D, Ozdemir O, Tasli F, Karatas M, Simsek C
Eur J Breast Health. 2022; 18(4):375-380.
PMID: 36248759
PMC: 9521291.
DOI: 10.4274/ejbh.galenos.2022.2022-1-5.
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Bhaludin B, Tunariu N, Koh D, Messiou C, Okines A, McGrath S
Eur Radiol. 2022; 32(9):6514-6525.
PMID: 35384456
DOI: 10.1007/s00330-022-08714-6.
Duodenal Metastasis in Triple-Negative Invasive Ductal Breast Carcinoma With Negative Mammography: A Case Report and Review of the Literature.
Khan N, Nguyen S, Teh P, Ranpura V, Bhatia T
Perm J. 2022; 25.
PMID: 35348061
PMC: 8784047.
DOI: 10.7812/TPP/20.244.
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
Mouabbi J, Hassan A, Lim B, Hortobagyi G, Tripathy D, Layman R
Breast Cancer Res Treat. 2022; 193(2):253-264.
PMID: 35347549
DOI: 10.1007/s10549-022-06572-w.
Rare sites of breast cancer metastasis: a review.
Di Micco R, Santurro L, Gasparri M, Zuber V, Fiacco E, Gazzetta G
Transl Cancer Res. 2022; 8(Suppl 5):S518-S552.
PMID: 35117130
PMC: 8797987.
DOI: 10.21037/tcr.2019.07.24.
The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis.
Makower D, Qin J, Lin J, Xue X, Sparano J
NPJ Breast Cancer. 2022; 8(1):4.
PMID: 35027533
PMC: 8758772.
DOI: 10.1038/s41523-021-00368-9.
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.
Yu J, Mu Q, Fung M, Xu X, Zhu L, Ho R
Pharmacol Ther. 2022; 236:108108.
PMID: 34999182
PMC: 9256851.
DOI: 10.1016/j.pharmthera.2022.108108.
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis.
Fitzpatrick A, Iravani M, Mills A, Childs L, Alaguthurai T, Clifford A
Clin Cancer Res. 2021; 28(6):1180-1191.
PMID: 34921020
PMC: 7612501.
DOI: 10.1158/1078-0432.CCR-21-3017.